Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of genetic factors on dyslipidemia in HIV-infected patients starting antiretroviral therapy.

AIDS (London, England) - 20 Feb 2013

Egaña-Gorroño Lander, Martínez Esteban, Cormand Bru, Escribà Tuixent, Gatell Jose, Arnedo Mireia

Abstract excerpt

OBJECTIVE: The impact of host genetic factors on the incidence of dyslipidemia in antiretroviral-naive HIV patients starting antiretroviral therapy (ART) is not clear. We assessed the role of single nucleotide polymorphisms (SNPs) identified from previous genome-wide association studies adjusting for the contribution of nongenetic factors. METHODS: We assessed 192 SNPs in an HIV cohort who started ART (1997-2008)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age Distribution
Share to Coinfection

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Administration Schedule

Share to Dyslipidemias

Share to Fasting

Share to HIV Protease Inhibitors

Share to HIV Seropositivity

Share to Patient Selection

Source

Identifiers

PMID: 23262498
DOI: 10.1097/QAD.0b013e32835d0da1

Genes

ABCA1
APOB
CETP
LIPC

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of genetic factors on dyslipidemia in HIV-infected patients starting antiretroviral therapy.PMID 23262498Read ↗

Genetic markers associated to dyslipidemia in HIV-infected individuals on HAART.Semantic proximity Read ↗

Association of single nucleotide polymorphisms with dyslipidemia in antiretroviral exposed HIV patients in a Ghanaian population: A case-control study.Semantic proximity Read ↗

Dyslipidemia in HIV-infected individuals: from pharmacogenetics to pharmacogenomics.Semantic proximity Read ↗

Contribution of genome-wide significant single-nucleotide polymorphisms and antiretroviral therapy to dyslipidemia in HIV-infected individuals: a longitudinal study.Semantic proximity Read ↗

Association of Single Nucleotide Polymorphisms with Dyslipidemia in Antiretroviral Exposed HIV Patients in a Ghanaian populationSemantic proximity Read ↗

Contribution of 20 single nucleotide polymorphisms of 13 genes to dyslipidemia associated with antiretroviral therapy.Semantic proximity Read ↗

Impact of genetic polymorphisms on the risk of lipid disorders in patients on anti-HIV therapy.Semantic proximity Read ↗

Contribution of APOA5, APOC3, CETP, ABCA1 and SIK3 genetic variants to hypertriglyceridemia development in Mexican HIV-patients receiving antiretroviral therapy.Semantic proximity Read ↗

Association between polymorphisms in genes involved in lipid metabolism and immunological status in chronically HIV-infected patients.Semantic proximity Read ↗

Polymorphisms in LPL, CETP, and HL protect HIV-infected patients from atherogenic dyslipidemia in an allele-dose-dependent manner.Semantic proximity Read ↗

APOC3 Gene Polymorphism and Antiretroviral Therapy-Induced Dyslipidemia in HIV-Infected Children.Semantic proximity Read ↗

Associations among race/ethnicity, ApoC-III genotypes, and lipids in HIV-1-infected individuals on antiretroviral therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.